Abstract
Fragile X syndrome (FXS) is caused by a lack of the fragile X mental retardation protein (FMRP) due to silencing of the Fmr1 gene. As an RNA binding protein, FMRP is thought to contribute to synaptic plasticity by regulating plasticity-related protein synthesis and other signaling pathways. Previous studies have mostly focused on the roles of FMRP within the hippocampus - a key structure for spatial memory. However, recent studies indicate that FMRP may have a more general contribution to brain functions, including synaptic plasticity and modulation within the prefrontal cortex. In this brief review, we will focus on recent studies reported in the prefrontal cortex, including the anterior cingulate cortex (ACC). We hypothesize that alterations in ACC-related plasticity and synaptic modulation may contribute to various forms of cognitive deficits associated with FXS.
Similar content being viewed by others
References
Antar, L.N., Afroz, R., Dictenberg, J.B., Carroll, R.C., and Bassell, G.J. (2004). Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses. J. Neurosci. 24, 2648–2655.
Bagni, C., and Greenough, W.T. (2005). From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat. Rev. Neurosci. 6, 376–387.
Bakker, C.E., Verheij, C., Willemsen, R., Vanderhelm, R., Oerlemans, F., Vermey, M., Bygrave, A., Hoogeveen, A.T., Oostra, B.A., and Reyniers, E. (1994). Fmr1 knockout mice: a model to study fragile X mental retardation. Cell 78, 23–33.
Bassell, G.J., and Gross, C. (2008). Reducing glutamate signaling pays off in fragile X. Nat. Med. 14, 249–250.
Bassell, G.J., and Warren, S.T. (2008). Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 60, 201–214.
Bear, M.F. (1996). A synaptic basis for memory storage in the cerebral cortex. Proc. Natl. Acad. Sci. USA 93, 13453–13459.
Bear, M.F., Huber, K.M., and Warren, S.T. (2004). The mGluR theory of fragile X mental retardation. Trends Neurosci. 27, 370–377.
Bliss, T.V., and Collingridge, G.L. (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31–39.
Bureau, I., Shepherd, G.M., and Svoboda, K. (2008). Circuit and plasticity defects in the developing somatosensory cortex of FMR1 knock-out mice. J. Neurosci. 28, 5178–5188.
Castren, M., Lampinen, K.E., Miettinen, R., Koponen, E., Sipola, I., Bakker, C.E., Oostra, B.A., and Castren, E. (2002). BDNF regulates the expression of fragile X mental retardation protein mRNA in the hippocampus. Neurobiol. Dis. 11, 221–229.
Centonze, D., Rossi, S., Mercaldo, V., Napoli, I., Ciotti, M.T., Chiara, V.D., Musella, A., Prosperetti, C., Calabresi, P., Bernardi, G., et al. (2007). Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome. Biol. Psychiatry 63, 963–973.
Chen, L., and Toth, M. (2001). Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience 103, 1043–1050.
Collingridge, G.L., Isaac, J.T., and Wang, Y.T. (2004). Receptor trafficking and synaptic plasticity. Nat. Rev. Neurosci. 5, 952–962.
Comery, T.A., Harris, J.B., Willems, P.J., Oostra, B.A., Irwin, S.A., Weiler, I.J., and Greenough, W.T. (1997). Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc. Natl. Acad. Sci. USA 94, 5401–5404.
Curia, G., Papouin, T., Seguela, P., and Avoli, M. (2009). Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome. Cereb. Cortex 19, 1515–1520.
D’Antuono, M., Merlo, D., and Avoli, M. (2003). Involvement of cholinergic and gabaergic systems in the fragile X knockout mice. Neuroscience 119, 9–13.
D’Hulst, C., and Kooy, R.F. (2007). The GABAA receptor: a novel target for treatment of fragile X? Trends Neurosci. 30, 425–431.
D’Hulst, C., De Geest, N., Reeve, S.P., Van Dam, D., De Deyn, P.P., Hassan, B.A., and Kooy, R.F. (2006). Decreased expression of the GABAA receptor in fragile X syndrome. Brain Res. 1121, 238–245.
Desai, N.S., Casimiro, T.M., Gruber, S.M., and Vanderklish, P.W. (2006). Early postnatal plasticity in neocortex of Fmr1 knockout mice. J. Neurophysiol. 96, 1734–1745.
Devys, D., Lutz, Y., Rouyer, N., Bellocq, J.P., and Mandel, J.L. (1993). The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat. Genet. 4, 335–340.
Dobkin, C., Rabe, A., Dumas, R., El Idrissi, A., Haubenstock, H., and Brown, W.T. (2000). Fmr1 knockout mouse has a distinctive strain-specific learning impairment. Neuroscience 100, 423–429.
Dolen, G., Osterweil, E., Rao, B.S., Smith, G.B., Auerbach, B.D., Chattarji, S., and Bear, M.F. (2007). Correction of fragile X syndrome in mice. Neuron 56, 955–962.
El Idrissi, A., Ding, X.H., Scalia, J., Trenkner, E., Brown, W.T., and Dobkin, C. (2005). Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse. Neurosci. Lett. 377, 141–146.
Feng, Y., Gutekunst, C.A., Eberhart, D.E., Yi, H., Warren, S.T., and Hersch, S.M. (1997). Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J. Neurosci. 17, 1539–1547.
Ferrari, F., Mercaldo, V., Piccoli, G., Sala, C., Cannata, S., Achsel, T., and Bagni, C. (2007). The fragile X mental retardation protein-RNP granules show an mGluR-dependent localization in the post-synaptic spines. Mol. Cell. Neurosci. 34, 343–354.
Frankland, P.W., Wang, Y., Rosner, B., Shimizu, T., Balleine, B.W., Dykens, E.M., Ornitz, E.M., and Silva, A.J. (2004). Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice. Mol. Psychiatry 9, 417–425.
Galvez, R., and Greenough, W.T. (2005). Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome. Am. J. Med. Genet. A 135, 155–160.
Godfraind, J.M., Reyniers, E., De Boulle, K., D’Hooge, R., De Deyn, P.P., Bakker, C.E., Oostra, B.A., Kooy, R.F., and Willems, P.J. (1996). Long-term potentiation in the hippocampus of fragile X knockout mice. Am. J. Med. Genet. 64, 246–251.
Gruss, M., and Braun, K. (2004). Age- and region-specific imbalances of basal amino acids and monoamine metabolism in limbic regions of female Fmr1 knock-out mice. Neurochem. Int. 45, 81–88.
Hagerman, B. (2002). Speech recognition threshold in slightly and fully modulated noise for hearing-impaired subjects. Int. J. Audiol. 41, 321–329.
Hagerman, P.J. (2008). The fragile X prevalence paradox. J. Med. Genet. 45, 498–499.
Hagerman, R.J., Berry-Kravis, E., Kaufmann, W.E., Ono, M.Y., Tartaglia, N., Lachiewicz, A., Kronk, R., Delahunty, C., Hessl, D., Visootsak, J., et al. (2009). Advances in the treatment of fragile X syndrome. Pediatrics 123, 378–390.
Hou, L., Antion, M.D., Hu, D., Spencer, C.M., Paylor, R., and Klann, E. (2006). Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression. Neuron 51, 441–454.
Hu, H., Qin, Y., Bochorishvili, G., Zhu, Y., van Aelst, L., and Zhu, J.J. (2008). Ras signaling mechanisms underlying impaired GluR1-dependent plasticity associated with fragile X syndrome. J. Neurosci. 28, 7847–7862.
Huang, Y.Y., and Kandel, E.R. (1995). D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus. Proc. Natl. Acad. Sci. USA 92, 2446–2450.
Huber, K.M., Gallagher, S.M., Warren, S.T., and Bear, M.F. (2002). Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl. Acad. Sci. USA 99, 7746–7750.
Igartua, I., Solis, J.M., and Bustamante, J. (2007). Glycine-induced long-term synaptic potentiation is mediated by the glycine transporter GLYT1. Neuropharmacology 52, 1586–1595.
Irwin, S.A., Idupulapati, M., Gilbert, M.E., Harris, J.B., Chakravarti, A.B., Rogers, E.J., Crisostomo, R.A., Larsen, B.P., Mehta, A., Alcantara, C.J., et al. (2002). Dendritic spine and dendritic field characteristics of layer V pyramidal neurons in the visual cortex of fragile-X knockout mice. Am. J. Med. Genet. 111, 140–146.
Kandel, E.R. (2001). The molecular biology of memory storage: a dialogue between genes and synapses. Science 294, 1030–1038.
Klann, E., and Dever, T.E. (2004). Biochemical mechanisms for translational regulation in synaptic plasticity. Nat. Rev. Neurosci. 5, 931–942.
Larson, J., Jessen, R.E., Kim, D., Fine, A.K., and du Hoffmann, J. (2005). Age-dependent and selective impairment of long-term potentiation in the anterior piriform cortex of mice lacking the fragile X mental retardation protein. J. Neurosci. 25, 9460–9469.
Lauterborn, J.C., Rex, C.S., Kramar, E., Chen, L.Y., Pandyarajan, V., Lynch, G., and Gall, C.M. (2007). Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome. J. Neurosci. 27, 10685–10694.
Li, J., Pelletier, M.R., Perez Velazquez, J.L., and Carlen, P.L. (2002). Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency. Mol. Cell. Neurosci. 19, 138–151.
McBride, S.M., Choi, C.H., Wang, Y., Liebelt, D., Braunstein, E., Ferreiro, D., Sehgal, A., Siwicki, K.K., Dockendorff, T.C., Nguyen, H.T., et al. (2005). Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome. Neuron 45, 753–764.
Menon, V., Leroux, J., White, C.D., and Reiss, A.L. (2004). Frontostriatal deficits in fragile X syndrome: relation to FMR1 gene expression. Proc. Natl. Acad. Sci. USA 101, 3615–3620.
Meredith, R.M., Holmgren, C.D., Weidum, M., Burnashev, N., and Mansvelder, H.D. (2007). Increased threshold for spike-timing-dependent plasticity is caused by unreliable calcium signaling in mice lacking fragile X gene FMR1. Neuron 54, 627–638.
Mineur, Y.S., Sluyter, F., de Wit, S., Oostra, B.A., and Crusio, W.E. (2002). Behavioral and neuroanatomical characterization of the Fmr1 knockout mouse. Hippocampus 12, 39–46.
Missale, C., Nash, S.R., Robinson, S.W., Jaber, M., and Caron, M.G. (1998). Dopamine receptors: from structure to function. Physiol. Rev. 78, 189–225.
Musumeci, S.A., Calabrese, G., Bonaccorso, C.M., D’Antoni, S., Brouwer, J.R., Bakker, C.E., Elia, M., Ferri, R., Nelson, D.L., Oostra, B.A., et al. (2007). Audiogenic seizure susceptibility is reduced in fragile X knockout mice after introduction of FMR1 transgenes. Exp. Neurol. 203, 233–240.
Nakamoto, M., Nalavadi, V., Epstein, M.P., Narayanan, U., Bassell, G.J., and Warren, S.T. (2007). Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors. Proc. Natl. Acad. Sci. USA 104, 15537–15542.
Napoli, I., Mercaldo, V., Boyl, P.P., Eleuteri, B., Zalfa, F., De Rubeis, S., Di Marino, D., Mohr, E., Massimi, M., Falconi, M., et al. (2008). The fragile X syndrome protein represses activitydependent translation through CYFIP1, a new 4E-BP. Cell 134, 1042–1054.
Nicoll, R.A., and Malenka, R.C. (1995). Contrasting properties of two forms of long-term potentiation in the hippocampus. Nature 377, 115–118.
Nimchinsky, E.A., Oberlander, A.M., and Svoboda, K. (2001). Abnormal development of dendritic spines in FMR1 knock-out mice. J. Neurosci. 21, 5139–5146.
Pacey, L.K., and Doering, L.C. (2007). Developmental expression of FMRP in the astrocyte lineage: implications for fragile X syndrome. Glia 55, 1601–1609.
Paradee, W., Melikian, H.E., Rasmussen, D.L., Kenneson, A., Conn, P.J., and Warren, S.T. (1999). Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Neuroscience 94, 185–192.
Price, T.J., Rashid, M.H., Millecamps, M., Sanoja, R., Entrena, J.M., and Cervero, F. (2007). Decreased nociceptive sensitization in mice lacking the fragile X mental retardation protein: role of mGluR1/5 and mTOR. J. Neurosci. 27, 13958–13967.
Qiu, L.F., Hao, Y.H., Li, Q.Z., and Xiong, Z.Q. (2008). Fragile X syndrome and epilepsy. Neurosci. Bull. 24, 338–344.
Reiss, A.L., and Dant, C.C. (2003). The behavioral neurogenetics of fragile X syndrome: analyzing gene-brain-behavior relationships in child developmental psychopathologies. Dev. Psychopathol. 15, 927–968.
Restivo, L., Ferrari, F., Passino, E., Sgobio, C., Bock, J., Oostra, B.A., Bagni, C., and Ammassari-Teule, M. (2005). Enriched environment promotes behavioral and morphological recovery in a mouse model for the fragile X syndrome. Proc. Natl. Acad. Sci. USA 102, 11557–11562.
Ronesi, J.A., and Huber, K.M. (2008). Metabotropic glutamate receptors and fragile x mental retardation protein: partners in translational regulation at the synapse. Sci. Signal. 1, pe6.
Sawaguchi, T., and Goldman-Rakic, P.S. (1991). D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 251, 947–950.
Shang, Y., Wang, H., Mercaldo, V., Li, X., Chen, T., and Zhuo, M. (2009). Fragile X mental retardation protein is required for chemically-induced long-term potentiation of the hippocampus in adult mice. J. Neurochem. 111, 635–646.
Tassone, F., Hagerman, R.J., Ikle, D.N., Dyer, P.N., Lampe, M., Willemsen, R., Oostra, B.A., and Taylor, A.K. (1999). FMRP expression as a potential prognostic indicator in fragile X syndrome. Am. J. Med. Genet. 84, 250–261.
Todd, P.K., and Mack, K.J. (2000). Sensory stimulation increases cortical expression of the fragile X mental retardation protein in vivo. Brain Res. Mol. Brain Res. 80, 17–25.
Tucker, B., Richards, R.I., and Lardelli, M. (2006). Contribution of mGluR and Fmr1 functional pathways to neurite morphogenesis, craniofacial development and fragile X syndrome. Hum. Mol. Genet. 15, 3446–3458.
Turner, G., Webb, T., Wake, S., and Robinson, H. (1996). Prevalence of fragile X syndrome. Am. J. Med. Genet. 64, 196–197.
Valentine, G., Chakravarty, S., Sarvey, J., Bramham, C., and Herkenham, M. (2000). Fragile X (fmr1) mRNA expression is differentially regulated in two adult models of activity-dependent gene expression. Brain Res. Mol. Brain Res. 75, 337–341.
Van Dam, D., D’Hooge, R., Hauben, E., Reyniers, E., Gantois, I., Bakker, C.E., Oostra, B.A., Kooy, R.F., and De Deyn, P.P. (2000). Spatial learning, contextual fear conditioning and conditioned emotional response in Fmr1 knockout mice. Behav. Brain Res. 117, 127–136.
Verkerk, A.J., Pieretti, M., Sutcliffe, J.S., Fu, Y.H., Kuhl, D.P., Pizzuti, A., Reiner, O., Richards, S., Victoria, M.F., Zhang, F.P., et al. (1991). Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905–914.
Volk, L.J., Pfeiffer, B.E., Gibson, J.R., and Huber, K.M. (2007). Multiple Gq-coupled receptors converge on a common protein synthesis-dependent long-term depression that is affected in fragile X syndrome mental retardation. J. Neurosci. 27, 11624–11634.
Wang, H., Ku, L., Osterhout, D.J., Li, W., Ahmadian, A., Liang, Z., and Feng, Y. (2004a). Developmentally-programmed FMRP expression in oligodendrocytes: a potential role of FMRP in regulating translation in oligodendroglia progenitors. Hum. Mol. Genet 13, 79–89.
Wang, M., Vijayraghavan, S., and Goldman-Rakic, P.S. (2004b). Selective D2 receptor actions on the functional circuitry of working memory. Science 303, 853–856.
Wang, H., Wu, L.J., Kim, S.S., Lee, F.J., Gong, B., Toyoda, H., Ren, M., Shang, Y.Z., Xu, H., Liu, F., et al. (2008). FMRP acts as a key messenger for dopamine modulation in the forebrain. Neuron 59, 634–647.
Wang, H., Fukushima, H., Kida, S., and Zhuo, M. (2009). Ca2+/calmodulin-dependent protein kinase IV links group I metabotropic glutamate receptors to fragile X mental retardation protein in cingulate cortex. J. Biol. Chem. 284, 18953–18962.
Weiler, I.J., Irwin, S.A., Klintsova, A.Y., Spencer, C.M., Brazelton, A.D., Miyashiro, K., Comery, T.A., Patel, B., Eberwine, J., and Greenough, W.T. (1997). Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc. Natl. Acad. Sci. USA 94, 5395–5400.
Wilson, B.M., and Cox, C.L. (2007). Absence of metabotropic glutamate receptor-mediated plasticity in the neocortex of fragile X mice. Proc. Natl. Acad. Sci. USA 104, 2454–2459.
Yan, Q.J., Rammal, M., Tranfaglia, M., and Bauchwitz, R.P. (2005). Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology 49, 1053–1066.
Yuen, E.Y., and Yan, Z. (2009). Dopamine D4 receptors regulate AMPA receptor trafficking and glutamatergic transmission in GABAergic interneurons of prefrontal cortex. J. Neurosci. 29, 550–562.
Zhang, Y.Q., Friedman, D.B., Wang, Z., Woodruff, E., 3rd, Pan, L., O’Donnell, J., and Broadie, K. (2005). Protein expression profiling of the drosophila fragile X mutant brain reveals up-regulation of monoamine synthesis. Mo.l Cell. Proteomics 4, 278–290.
Zhao, M.G., Toyoda, H., Ko, S.W., Ding, H.K., Wu, L.J., and Zhuo, M. (2005). Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome. J. Neurosci. 25, 7385–7392.
Zhuo, M. (2008). Cortical excitation and chronic pain. Trends Neurosci. 31, 199–207.
Zhuo, M. (2009). Plasticity of NMDA receptor NR2B subunit in memory and chronic pain. Mol. Brain 2, 4.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Mercaldo, V., Descalzi, G. & Zhuo, M. Fragile X mental retardation protein in learning-related synaptic plasticity. Mol Cells 28, 501–507 (2009). https://doi.org/10.1007/s10059-009-0193-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10059-009-0193-x